ASCP Specialist In Blood Banking (SBB) Practice Exam

Granulocyte transfusions are primarily used to increase the white blood cell counts, specifically neutrophils, in patients who are neutropenic. Neutropenia, a condition characterized by an abnormally low level of neutrophils, often occurs in patients undergoing chemotherapy, bone marrow disorders, or certain infections. The transfusion of granulocytes provides an immediate source of these vital immune cells, helping to bolster the body's defense against infections at a critical time when the patient is particularly vulnerable. Other options, while they may involve blood components, do not reflect the primary purpose of granulocyte transfusions. For instance, increasing platelet counts pertains to platelet transfusions aimed at providing hemostatic support. Enhancing plasma protein levels is related to products like albumin or fresh frozen plasma, not granulocytes. Lastly, while organ function in transplant patients may be influenced by overall immune function, granulocyte transfusions specifically target white blood cell counts rather than directly improving organ function. Thus, the correct focus on neutrophil levels helps clarify the fundamental use of granulocyte transfusions in medical practice.